Eric Springman Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

12/2020

Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Springman Research Topics

Disease

2	Inflammation (Inflammations) 01/2023 - 01/2018
2	Cystic Fibrosis (Mucoviscidosis) 11/2021 - 01/2018
1	COVID-19 01/2023
1	Lung Diseases (Lung Disease) 11/2021
1	Blister (Bulla) 12/2020
1	Bullous Pemphigoid (Pemphigoid) 12/2020
1	Colonic Neoplasms (Colon Cancer) 02/2012
1	Neoplasms (Cancer) 02/2012
1	Prostatic Neoplasms (Prostate Cancer) 02/2012
1	Osteoporosis 12/2005
1	Bone Resorption 12/2005

Drug/Important Bio-Agent (IBA)

3	acebilustatIBA 01/2023 - 01/2018
2	Leukotriene B4IBA 01/2023 - 12/2020
2	leukotriene A4 hydrolaseIBA 11/2021 - 12/2020
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 12/2020
1	EnzymesIBA 12/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2020
1	InterleukinsIBA 12/2020
1	Macrophage Colony-Stimulating FactorIBA 12/2020
1	Interleukin-8 (Interleukin 8)IBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	Interleukin-18 (Interleukin 18)IBA 12/2020
1	Interleukin-10 (Interleukin 10)IBA 12/2020
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	N- (3- (1H- indol- 4- yl)- 5- (2- methoxyisonicotinoyl)phenyl)methanesulfonamideIBA 02/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2012
1	Bevacizumab (Avastin)FDA Link 02/2012
1	Cathepsin KIBA 12/2005
1	CollagenIBA 12/2005

Therapy/Procedure

1	Therapeutics 01/2018